Poly Medicure Key Ratios
NSE: POLYMED | BSE: 531768
₹1,712.60
As on 27-Aug-2026IST
Market cap
₹17,353 Cr
Revenue (TTM)
₹1,997 Cr
P/E Ratio
55.1
P/B Ratio
5.5
Div. Yield
0.2 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -1.71 | 30.30 | 18.31 | 18.94 | 19.26 |
| EBIT | 23.11 | 7.19 | -9.66 | 10.44 | 13.82 |
| Net Profit | 29.77 | -7.58 | -10.48 | 14.19 | 16.88 |
| EPS | 29.77 | -7.61 | -11.93 | 11.52 | 14.29 |
| Book Value | -- | -- | 12.10 | 33.27 | 24.89 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 21.94 | 19.48 | 16.68 | 17.23 | 22.31 |
| Net Margin
| 18.94 | 16.82 | 14.56 | 16.02 | 19.25 |
| Return on equity
| 15.38 | 15.15 | 10.63 | 10.94 | 16.01 |
| Return on Capital
| 19.44 | 18.91 | -- | 14.05 | 20.37 |
| Return on Assets
| 12.38 | 11.87 | 8.63 | 8.89 | 12.99 |
| Debt to Equity (x)
| -- | -- | 0.02 | 0.11 | 0.06 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
10.63
Higher than Peers by 10.19
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
10.63
|
10.94
|
16.01
|
19.09
|
15.42
|
14.29
|
|||||
|
Peer Median
|
0.44
|
9.88
|
14.03
|
12.58
|
14.29
|
18.94
|
ROA
8.63
Higher than Peers by 8.23
Profit after tax / Average Total assets * 100
EBIT Margin
16.68
Higher than Peers by 22.04
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
16.68
|
17.23
|
22.31
|
21.56
|
18.85
|
17.45
|
|||||
|
Peer Median
|
-5.36
|
--
|
11.92
|
17.72
|
10.64
|
19.57
|
Net Margin
14.56
Higher than Peers by 13.87
Net profit / Total Income (Net sales plus other income) * 100
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
18.31
Lower than Peers by 5.61
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
18.31
|
12.30
|
21.37
|
23.36
|
20.82
|
17.37
|
|||||
|
Peer Median
|
23.92
|
--
|
19.29
|
35.34
|
69.01
|
251.95
|
EBIT Growth
-9.66
Lower than Peers by 29.80
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
-9.66
|
-13.27
|
25.62
|
41.06
|
30.53
|
-4.68
|
|||||
|
Peer Median
|
20.14
|
--
|
21.41
|
45.38
|
4,139.53
|
1,176.43
|
Net Profit Growth
-10.48
Lower than Peers by 26.58
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
-10.48
|
-5.27
|
31.09
|
44.05
|
22.37
|
7.82
|
|||||
|
Peer Median
|
16.09
|
--
|
147.16
|
65.85
|
686.54
|
381.29
|
EPS Growth
-11.93
Lower than Peers by 29.31
Year on year growth in earnings per share
Book Value Growth
--
--
Year on year growth in book value per share
Solvency
Debt to Equity
0.02
Lower than Peers by 0.01
Total debt / Net worth
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
Current Ratio
3.37
Higher than Peers by 0.96
Current Assets / Current Liabilities and Provisions
Quick Ratio
2.62
Higher than Peers by 0.32
(Current Assets - Inventory) / Current Liabilities and Provisions
Interest Coverage
20.04
Higher than Peers by 17.84
Earning before interest and taxes (EBIT) / Interest Expenses
Operating Efficiency
Debtors to sales
26.59
Higher than Peers by 15.98
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
26.59
|
28.33
|
20.94
|
19.62
|
21.11
|
22.39
|
|||||
|
Peer Median
|
10.62
|
--
|
24.00
|
33.89
|
21.39
|
15.78
|
Asset Turnover
0.56
Lower than Peers by 0.16
Sales / Average Total Assets
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
55.07
Lower than Peers by 15.34
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
55.07
|
37.47
|
67.10
|
59.04
|
51.01
|
62.11
|
|||||
|
Peer Median
|
70.41
|
39.72
|
20.16
|
51.65
|
61.00
|
61.43
|
Price / Book Value
5.45
Lower than Peers by 6.48
Current share price divided by book value per share in the latest financial year
Dividend Yield
0.20
--
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
30.74
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
30.74
|
21.79
|
41.75
|
36.47
|
30.02
|
36.41
|
|||||
|
Peer Median
|
--
|
19.54
|
14.45
|
25.55
|
11.25
|
17.58
|
Market Cap
17,353
Higher than Peers by 17,059
Current Share price multiplied by latest total number of shares outstanding